(Q42437587)

English

Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients

scientific article published on April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1 reference

based on heuristic

inferred from title

author name string

Velussi M

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Cernigoi AM

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

De Monte A

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Dapas F

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Caffau C

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Zilli M

6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

871-879

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose intolerance in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible roles of insulin, glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Carbohydrate intolerance associated with reduced hepatic glucose phosphorylating and releasing enzyme activities and peripheral insulin resistance in alcoholics with liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Alcohol ingestion, liver glutathione and lipoperoxidation: metabolic interrelations and pathological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease. Evidence of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased hepatic glutathione in chronic alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid peroxidation in acrylonitrile-treated rats, evidenced by elevated ethane production

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetaminophen hepatotoxicity. An alternative mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic control may influence the increased superoxide generation in diabetic serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of CCL4-induced liver cirrhosis by silymarin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma levels of glutathione and malondialdehyde after acute ethanol ingestion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antioxidant activity of silybin in vivo during long-term iron overload in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Silymarin, an inhibitor of lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

[Studies on elimination of silymarin in cholecystectomized patients. I. Biliary and renal elimination after a single oral dose]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin uptake by the human alcoholic cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Feedback inhibition of insulin secretion is altered in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980255-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(97)80255-3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42437587&oldid=1944929468"